Drug intelligence / Profile preview

lysine glutamate

Development stage
Unknown
Lead developer
DuPont
Modality
Small Molecules
Administration
Intradermal, Topical
01

Overview

Lysine glutamate is the 1:1 salt of **L-lysine** and **L-glutamic acid** with CAS number 5408-52-6. It is a non-covalent amino-acid salt rather than the covalent lysylglutamic-acid dipeptide known as Vilon. It has been used as a chemical, nutritional, and pharmaceutical-formulation ingredient, and was the subject of a historical Betamed Pharmaceuticals patent describing topical or intradermal administration for treatment of herpes simplex infections. A specific molecular antiviral target and validated mechanism of action have not been established. ([pubchem.ncbi.nlm.nih.gov](https://pubchem.ncbi.nlm.nih.gov/compound/L-Lysine-L-glutamate))

Other names
L-glutamic acid L-lysine saltL-glutamic acid, compound with L-lysine (1:1)L-lysine L-glutamateL-lysine L-glutamate saltL-lysine, L-glutamate (1:1)L-lysine-L-glutamic acidNSC 10855NSC10855NSC-10855lysine glutamate

Beyond the preview

Go deeper on lysine glutamate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lysine glutamate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call